HomeBUSINESS
BUSINESS

Japan Drug Makers Downsizing Parent Companies; Takeda Sheds Over 1,000 People in Divestitures, R&D Rejig
(Jul.3.2018)

By Reiji Anasako

As Japanese drug makers seek an increasingly leaner workforce at their parent companies, Takeda Pharmaceutical saw its employee headcount decrease more than 1,000 in FY2017 through divestitures and R&D revamps. Second-tier players like Shionogi are transferring their staffers to shared service subsidiaries, illustrating that companies are upping their cost-cutting efforts through the redeployment of human resources ...
(LOG IN FOR FULL STORY)